CC BY
0©Jassim NA, Yasiry D, Hummadi YA.
This work is licensed under a Creative Commons Attribution 4.0 International L
SURVEY
Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of COVID-19: An Online Survey
Nizar Abduiateef Jassim1 , Dina Yasiry2 , Yasameen Abbass Hummadi3
Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq, 2Rheumatology Unit, Department of Medicine, Baghdad Teaching Hospital, Medical City, Baghdad, Iraq, 3Department of Medicine, College of Medicine, Al-Nahrain University, Baghdad, Iraq
ABSTRACT
Background: The current crisis COVID-19 has affected the already challenging management of rheumatic diseases. Since no evidence-based approach is yet available, this survey was conducted to explore the Iraqi rheumatologists' attitude in the era of COVID-19 and how they have been managing their patients, especially with the continuously updating and sometimes conflicting reports. Patients and methods: A cross-sectional survey was distributed online via telephone and social media to rheumatologists in Iraq. A questionnaire was conducted about methods of patient education, preventive measures, and methods of arranging visits and treatment. In addition, an inquiry about the similarity of the practice between their local institutions and global ones. Results: 144 rheumatologists answered the 14 obligatory questions, of which the majority were specialists. 122 rheumatologists participated in patient education. Half of participants used online information, social media and websites as a source to communicate and interact with their patients for education about COVID-19-related issues. Conclusion: Despite the lack of solid guidelines regarding the management of rheumatic diseases during the COVID-19 crisis, this survey showed the majority of Iraqi rheumatologists to be familiar with the updating recommendations. Also, as the majority are waiting for stronger evidence before attempting to embrace controversial issues, surely this reflects a responsible and scientific attitude.
Mediterr J Rheumatol 2020;31(Suppl 2):299-303 https://doi.org/10.31138/mjr.31.3.299
Article Submitted: 15 May 2020; Revised Form: 16 Jul 2020; Article Accepted: 30 Jul 2020; Available Online: 21 Sep 2020
Keywords: COVID-19, Iraq, attitude, rheumatologist, survey
Corresponding Author:
Dina Yasiry
Department of Medicine, Baghdad
Teaching Hospital
Medical City, Bab Al-Muatham
Baghdad, Iraq
Tel.: +9647707117771
E-mail: dinashakiryousif@gmail.com
INTRODUCTION
Over the past few months, the world has been through a crisis described as the most influential in modern times. Coronavirus disease 2019 (COVID-19) has rapidly invaded the globe. The first recorded case of COVID-19 in Iraq was on 24th February 2020. Until 8th May 2020, the total number of confirmed
cases reached 2,543 with, 102 deaths.1 The World Health Organization (WHO) praised Iraq for early endorsement of preventive measures, which has proven to be the only effective strategy so far, since no cure or vaccine is yet available.2 The management of patients with rheumatic diseases on immunosup-pressants during the pandemic is very
Cite this article as: Jassim NA, Yasiry D, Hummadi YA. Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of 299 COVID-19: An Online Survey. Mediterr J Rheumatol 2020;31(Suppl 2):299-303.
challenging. Such patients suffer an already dysregulated immune response, increasing the risk for a more severe infection. Health care workers themselves are at well-known risk for acquiring COVID-19 due to higher viral loads and repetitive exposures.3 Until now, no evidence-based approach in managing rheumatic diseases during the pandemic has been established. The published global recommendations4-7 are hindered by the lack of strong evidence and being influenced by experts' opinions, which may not be suitable for different regions and health care systems. With these facts in mind, this survey was conducted to understand rheumatologists' attitude, and to facilitate making a unified local protocol for patients with rheumatic diseases in Iraq that is met with comfort among practicing physicians.
METHODS
A questionnaire was formulated by the authors via Google Forms, submitted online and distributed by telephone, applications and social media on March 2020 for practicing Iraqi specialists and postgraduate students in the Rheumatology field.
The questionnaire had 14 obligatory single-choice questions: these included genders, work title, methods and opinions on patient education, preventive measures, scheduling visits, and if immunosuppressants and steroids were required. Questionnaire inquired which action was taken while COVID-19 contact or infection occurred, also prophylaxis for patients and health care provider. The last question was to be answered on a scale of 1 to 10 on similarity between the practices of the participants' organisation and the international ones. The obtained results are frequencies of answers, and are expressed as numbers and percentages of total. The results were analysed and obtained by Google Forms and Microsoft Excel software.
RESULTS AND DISCUSSION
To the best of our knowledge, this is the first published survey from Iraq addressing the attitude of rheumatolo-gists during COVID-19.
Of the 144 participants, 93 were specialists, 41 were postgraduate students. This reflects the excellent participation of students in academic projects, especially those related to hot topics like the current pandemic. The presence of only 2 practitioners highlights that Primary Health Care facilities are not optimal, and explains why most rheumatic patients insist on seeing a specialist,8 possibly due to drugs and lab shortage and the lack of updated knowledge.9-11 (Figure 1) Seventy-six rheumatologists (52.8%) were males. Involvement in patient education about COVID-19 and necessary preventive measures was reported in 122 participants (84.7%), which is highly expected, since such
Figure 1. The current title of participants.
patients are at constant risk of infection. The other 22 (15.3%) stated that they haven't been involved, and no reason is provided in the survey; however, they might had not been practicing due to curfew and closure of some clinics in certain cities, self-isolation for health-related reasons, being retired, or exclusive private sector work (Table 1 ). Since the answers were given anonymously, it was not possible to exclude those 22 participants from answering further questions. Seventy-two participants used online information, social media and websites to distribute information to their patients as a source of education. Other sources (Figure 2), eg, social media and internet, are expected to dominate as a source of communication and news in all age groups. Almost all hospitals and private clinics now have educating public Facebook and social media pages to interact with patients, and offer education and lifestyle advices. These pages were used from the beginning of the pandemic to spread knowledge about preventive methods. Many patients also communicate with their rheumatologists and postgraduate students through applications like
Figure 2. The distribution of the answers for the source of information in patient education.
Table 1. The results of participants' answers to the questions of the survey.
Variable Results 144 (100%)
Gender Male 76 (52.8%)
Female 68 (47.2%)
Educating patients with rheumatic diseases about the pandemic and the necessary preventive measures Yes 122 (84.7%)
No 22 (15.3%)
Do you think it is necessary to carry-on seeing your patients according to their pre-arranged appointments? Yes 29 (20.1%)
Routine visits must be cancelled, urgent complains are attended only. 104 (72.2%)
Maybe 11 (7.6%)
Opinion about immunosuppressant use during the pandemic, given that neither infection nor a history of contact occurred? Continue 127 (88.2%)
Stop immunosuppressants 17 (11.8%)
Do you recommend starting patients on hydroxychloro-quine as prophylaxis? Yes 21 (14.6%)
No 58 (58.3%)
Not sure 39 (27.1%)
Do you recommend patients to receive routine vaccines as scheduled? Yes, arrange vaccines according to timed schedule. 58 (40.3%)
No, this can be delayed until the pandemic clears-off. 86 (59.7%)
Proved COVID-19 patient with Rheumatoid arthritis on Methotrexate, folate & prednisolone. what will your advice be about prednisolone? Stop 42 (29.2%)
Continue 60 (41.7%)
Decrease the dose 42 (29.2%)
As a health care provider, have you been taking Hydroxychloroquine for prevention against COVID-19? Yes, I am on a weekly dose. 25 (17.4%)
No, I haven't, not enough data. 116 (80.5%)
I have a contraindication to it. 3 (2.1%)
WhatsApp, Viber, and others in their daily routine work to confirm schedules and review laboratory results. Luckily, this source was also used to communicate with patients. Seventy-two (50%) believed that health-care providers, the immunosuppressed, people in crowded places and infected individuals should wear masks, while 46% believed all individuals should wear masks as demonstrated in Figure 3. Actually, experts believe that stepping up the protection is guided by mask availability, and the different opinions come from variable recommendations. WHO recommends special masks for health-care workers working with proven/suspected COVID-19 cases.12 The Centre for Disease Control and Prevention (CDC) recently
recommends everyone wear a cloth mask to prevent the spread, rather than protecting the wearer.13 One hundred four physicians believed that routine visits should be cancelled, and only urgent complains must be attended, which agrees with the global attitude4-7 as shown in Table 1.
When the participants asked about their attitude, in case no COVID-19 infection/contact had occurred, 127 (88.2%) rheumatologists stated that immunosup-pressants are not to be stopped. This is similar to the global attitude; which shows a considerable interest and investment in the pandemic global knowledge.14 Eighty-four participants (58.3%) chose not to give their patients
Figure 3. The distribution of the answers regarding the concept of wearing a mask.
Figure 4. The participants' answers regarding advice given to patients with contact with a documented COVID-19 case.
hydroxychloroquine as prophylaxis against COVID-19 (Table 1). This might be due to lack of compelling evidence, concern of shortage on Lupus patients and other indications.(15) Still, the promising reports and its known safety encouraged 21 participants to use it. Eighty-six decided to delay routine vaccination, while 58 (40.3%) thought vaccinations should proceed as scheduled (Table 1). This difference is probably due to the pre-existing irregularities in the schedule due to the unfortunate interrupted supply of vaccination locally, which possibly led to the underestimation of its crucial importance. Another explanation is that some might think that deferring the vaccine would spare patients a hospital visitation during the pandemic.
In case of contact with a documented COVID-19 patient, 63% of participants chose to advise their patients to arrange an urgent test and seek medical help, which is not the protocol indorsed by the WHO, especially if resources are not widely available.16 Twenty (14%) decided to wait-and-see, which is an acceptable approach, but definitely isn't enough; 30 (21%) decided to advise for preventive measures, which might be reasonable to minimize community spread, but would not be enough or proper for the patient. (Figure 4) In case a patient on immunosuppressive drugs was proved to be infected with COVID-19, 76 participants (53%) decided to stop all medication except for hydroxy-chloroquine and low dose of steroids;17,18 53 (37%) stated they would stop all medication with admission; 15 (10%) answered with an ICU admission (Figure 5). Actually, a single/multiple answer(s) would apply here according to case characteristics and severity. Another question was, if a patient with Rheumatoid arthritis on methotrexate, folate and 7.5mg prednisolone developed COVID-19. While inquiring about steroids status, sixty participants (41.7%) advised to continue prednisolone, while 42 (29.2%) chose to decrease dose. It is well known that chronic low dose steroid should
not be stopped abruptly, but this can be a reflection of the conflicting reports.17 Eighty percent (116) of participants thought current data is not enough to support the use of hydroxychloroquine for COVID-19 prophylaxis, while 25 (17.4%) stated that they are already on a weekly dose, and 3 (2.1%) had a contraindication for the drug (Table 1).19
Seven participants (4.9%) thought that their institution's practice highly differs from the global attitude and assessed similarity to be 1/10, while 11 (7.6%) thought the similarity is 10/10. (Figure 6) Obviously, the majority believe their approach is close to that of global protocols because nearly 90% of the participants believed that the similarity is 5 or more, while only 10% believed otherwise.
CONCLUSION
Despite that evidence-based global guidelines on how to manage rheumatic diseases during the COVID-19 pandemic are much needed, it is clear from the results of this survey that the majority of Iraqi rheumatologists are familiar with the continuously updating recommenda-
Figure 5. The appropriate action when a patient with rheumatic disease developed COVID-19.
7
Figure 6. The distribution of 144 participants' answers regarding their perception of similarity between their organizations' protocols and global attitude.
tions. Also, the majority are waiting for stronger evidence on controversial issues, which reflects a responsible and scientific attitude.
AUTHOR CONTRIBUTIONS
All authors designed and distributed the survey, all authors contributed to manuscript revision and agreed to the final version and all are accountable for the contents.
ACKNOWLEDGMENT
The authors are thankful for their 144 colleagues who took the time and effort to participate in the survey. Also, a" thank you" for the Iraqi League for Bone and Joint Health scientific committee for their effort in distributing the survey online.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ETHICAL APPROVAL AND INFORMED CONSENT STATEMENTS
The Ethical Committee of College of Medicine, Baghdad University, Iraq approved the protocol of the survey, surely the participants willingly answered the questions and the forms was answered completely anonymously.
REFERENCES
1. Iraq Coronavirus: 2,534 Cases and 102 Deaths-Worldometer [Internet]. [cited 2020 May 8]. Available from: https://www. worldometers.info/coronavirus/country/iraq/
2. Lim J, Jeon S, Shin H-Y, Kim MJ, Seong YM, Lee WJ, et al. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR. J Korean Med Sci 2020;35(6):e79.
3. Wu Y-C, Chen C-S, Chan Y-J. The outbreak of COVID-19: An overview. J Chin Med Assoc 2020 Mar;83(3):217-20.
4. EULAR | EULAR Guidance for patients COVID-19 outbreak [Internet]. [cited 2020 May 3]. Available from: https://www.eular. org/eular_guidance_for_patients_covid19_outbreak.cfm
5. Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, et al. American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic. Arthritis Rheumatol 2020;72:1241-51.
6. COVID-19: guidance for rheumatologists | British Society for Rheumatology [Internet]. [cited 2020 May 3]. Available from:
11
12
https://www.rheumatology.org.uk/news-policy/details/Covid19-Coronavirus-update-members
Overview | COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders | Guidance | NICE [Internet]. [cited 2020 May 3]. Available from: https://www.nice.org. uk/guidance/ng167
Puchner R, Edlinger M, Mur E, Eberl G, Herold M, Kufner P, et al. Interface Management between General Practitioners and Rheumatologists—Results of a Survey Defining a Concept for Future Joint Recommendations. PLoS ONE 2016 Jan 7;11(1). Memel DS, Kirwan JR. General practitioners' knowledge of functional and social factors in patients with rheumatoid arthritis. Health Soc Care Community 1999;7(6):387-93. 10. McCarthy EM, Azeez MA, Fitzpatrick FM, Donnelly S. Knowledge, Attitudes, and Clinical Practice of Rheumatologists in Vaccination of the At-Risk Rheumatology Patient Population. J Clin Rheumatol. 2012 Aug;18(5):237-241.
Burnham G, Hoe C, Hung YW, Ferati A, Dyer A, Hifi TA, et al. Perceptions and utilization of primary health care services in Iraq: findings from a national household survey. BMC Int Health Hum Rights 2011 Dec 16;11:15.
Conversation PG& CDM The. Should We All Be Wearing Face Masks? Here's Why Experts Are So Conflicted [Internet]. ScienceAlert. [cited 2020 May 3]. Available from: https://www. sciencealert.com/this-is-why-advice-on-whether-you-should-wear-a-mask-is-just-so-confusing 13. Use Cloth Face Coverings to Help Slow Spread | CDC [Internet]. [cited 2020 May 3]. Available from: https://www.cdc.gov/ coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html
CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2020 May 3]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html
Rheumatologists May Face Ethical Dilemmas With HCQ Shortage During the COVID-19 Pandemic - Infectious Disease Advisor [Internet]. [cited 2020 May 3]. Available from: https:// www.infectiousdiseaseadvisor.com/home/topics/covid19/ rheumatologists-face-ethical-dilemma-with-hcq-shortage-during-covid-19-pandemic/ 16. WHO-COVID-19-lab_testing-2020.1-eng.pdf [Internet]. [cited 2020 May 3]. Available from: https://apps.who.int/iris/bitstream/ handle/10665/331509/WHO-COVID-19-lab_testing-2020.1-eng. pdf
Frontiers | Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature | Medicine [Internet]. [cited 2020 May 3]. Available from: https://www. frontiersin.org/articles/10.3389/fmed.2020.00170/full Bogdanos DP, Daniil Z, Zakynthinos E, Gourgoulianis K, Sakkas LI. When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients? Mediterr J Rheumatol 2020;31(1):94-7. Gendrot M, Javelle E, Clerc A, Savini H, Pradines B. et al. "Chlo-roquine as a prophylactic agent against COVID-19?." Int J Antimi-crob Agents 2020;55(6):105980.
14,
15
17
19,
